Isolated bilateral metastatic mass of malignant melanoma as shown by F-18 Fluorodeoxyglocose Positron Emission Tomography/Computed Tomography

Abstract

Melanoma of unknown primary is the diagnostic challenge as well as is associated with poor prognosis for the patient. We present a 79 years old male patient who was presented with hypermetabolic adrenal mass lesions. The biopsy results shown metastatic malignant melanoma.

Keywords

• malignant melanoma
• positron emission tomography
• adrenal mass

References

1. Drouet, C., Morel, O., & Boulahdour, H. (2017). Bilateral Huge Incidentalomas of Isolated Adrenal Metastases From Unknown Primary Melanoma Revealed by 18F-FDG PET/CT. Clinical nuclear medicine, 42(1), e51–e53. https://doi.org/10.1097/RLU.0000000000001417
2. Seshadri, N., Wat, J., & Balan, K. (2006). Bilateral adrenal metastases from malignant melanoma: concordant findings on (18)F-FDG and (18)F-FDOPA PET. European journal of nuclear medicine and molecular imaging, 33(7), 854–855. https://doi.org/10.1007/s00259-006-0101-y
3. Bertagna, F., Biasiotto, G., Rodella, C., Werner, T., Giubbini, R., & Alavi, A. (2009). Massive bilateral adrenal gland metastases from melanoma diagnosed by F18-FDG-PET/CT. Japanese journal of radiology, 27(9), 392–393. https://doi.org/10.1007/s11604-009-0358-8
4. Kumar, R., Mavi, A., Bural, G., & Alavi, A. (2005). Fluorodeoxyglucose-PET in the management of malignant melanoma. Radiologic clinics of North America, 43(1), 23–33. https://doi.org/10.1016/j.rcl.2004.09.011
5. Dimitrakopoulou-Strauss, A., Strauss, L. G., & Burger, C. (2001). Quantitative PET studies in pretreated melanoma patients: a comparison of 6-[18F]fluoro-L-dopa with 18F-FDG and (15)O-water using compartment and noncompartment analysis. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 42(2), 248–256.